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A sustainable and scalable process for the production of a new mixture of 20 
fructooligosaccharides (FOS) was developed using a continuous-flow approach based 21 
on an immobilized whole cells-packed bed reactor. The technological transfer from a 22 
classical batch system to an innovative flow environment allowed a significant 23 
improvement of the productivity. Moreover, the stability of this production system 24 
was ascertained up to 7 days of continuous working. These results suggest the 25 
suitability of the proposed method for a large-scale production of the desired FOS 26 
mixture, in view of a foreseeable use as a novel prebiotic preparation.  27 
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1. Introduction  33 
Biocatalysis and flow reactor technology are widely considered some of the key 34 
technologies intrinsically compatible with the principle of green chemistry (Bryan, et al. 2013; 35 
Ley, 2012). However, even if the effectiveness of their combination has been recently 36 
demonstrated (Tamborini, Romano, Pinto, Bertolani, Conti & Molinari, 2012; Tamborini et 37 
al., 2013; Itabaiana, de Mariz e Miranda & De Souza, 2013a; Itabaiana, et al., 2013b), the 38 
potential of biocatalysis in flow chemistry reactors is far from being fully exploited.  39 
In the present paper, we describe an application of this innovative approach in the food 40 
field, by proposing a method for preparing fructooligosaccharides (FOS). 41 
FOS are alternative sweeteners with a number of nutritional interesting properties: they 42 
are calorie free, non-cariogenic and are considered as soluble dietary fibres (Barclay, Ginic-43 
Markovic, Cooper & Petrovsky, 2012). The energy value of FOS is 4.2‒9.5 kJ/g. The 44 
sweetness of FOS depends on the composition of the mixture and the sweetness of the main 45 
components, i.e., 1-kestose, 1-nystose, and 1-fructofuranosylnystose, relative to 10% sucrose 46 
solution is 31%, 22%, and 16%, respectively (Antošová & Polakovič, 2001). Furthermore, 47 
they induce important beneficial physiological effects, such as a prebiotic effect, an improved 48 
mineral absorption and decreased levels of serum cholesterol, triacylglycerols and 49 
phospholipids (Daubioul, et al., 2002; Giacco, et al., 2004). Currently, FOS are increasingly 50 
included in food products and infant formulas due to their prebiotic effect that stimulates the 51 
growth of non-pathogenic intestinal microflora (Sabater-Molina, Larqué, Torrella & Zamora, 52 
2009).  53 
FOS are found in several kinds of plants and vegetables such as banana, onion, asparagus 54 
roots and artichokes, however, the supply is rather limited owing to their limited content in 55 
natural sources. Therefore, they are industrially produced following two different approaches. 56 
The first is based on inulin degradation, whereas the second one employs sucrose 57 
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transformation catalyzed by fructosyltransferase (FTase) or β-fructofuranosidase (FFase) from 58 
microbial sources. Industrial scale production of FOS is commonly performed by either 59 
soluble enzymes in batch reactions (Hidaka, Eida, Adachi & Saitoh, 1987) and by 60 
immobilized enzymes using continuous fixed-bed reactors (Yun, Kang & Song, 1995; Park, 61 
Lim, Kim, Park & Kim, 2005). Immobilized FTase from Aureobasidium pullulans and the 62 
immobilized whole cells have been used in a packed bed reactors for the continuous 63 
production of FOS at a plant scale (Jung, Bang, Oh & Park, 2011; Vaňková, Onderková, 64 
Antošová & Polakovič, 2008) 65 
Recently, we used the strain of Cladosporium cladosporioides MUT 5506 endowed with 66 
transfructosylating activity to produce a new mixture of FOS from a 600 g/L solution of 67 
sucrose in high yields (Zambelli, et al., 2014; Zambelli et al., 2015). In this mixture, we were 68 
able to identify and fully characterize the non-conventional disaccharide blastose (6-O-β-D-69 
fructofuranosyl-α,β-D-glucopyranoside), whose prebiotic activity was unknown (Zambelli, et 70 
al., 2014). 71 
In the present work, we aimed at demonstrating the advantages of performing the 72 
previously described biotransformation in a flow-chemistry reactor, with the final aim of 73 
predisposing a suitable process for the sustainable and scalable production of the desired FOS 74 
mixture, whose potential use as a novel prebiotic preparation can be easily foreseen and is at 75 
present under investigation by us. To this purpose, a C. cladosporioides MUT 5506 strain was 76 
used as an immobilized mycelium into a packed bed reactor to improve the productivity, the 77 
efficiency and the scalability of the reported batch biotransformation. The innovative 78 
application of whole microbial cells into a flow chemistry reactor combines the advantages of 79 
an easy to produce biocatalyst with a process-intensification technology. Moreover, the use of 80 
a continuous-flow approach based on a packed bed reactor guarantees improved mass transfer 81 
and recyclability of the solid catalyst (Kirschning, Solodenko & Mennecke, 2006). The 82 
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produced FOS mixture, as well as the isolated non-conventional blastose, were submitted to a 83 
preliminary in vitro study to assess their ability to promote the growth – as sole carbon 84 
sources – of selected probiotic strains, thus giving a first indication of their suitability for a 85 
potential application as prebiotics.  86 
 87 
2. Materials and methods 88 
2.1. Materials  89 
Sucrose, glucose, fructose and p-anisaldehyde were purchased from Sigma-Aldrich. 90 
Standards of 1-Nystose and 1-kestose were purchased from Fluka (DE). A standard of 1-F-91 
fructofuranosylnystose was purchased from Megazyme. Actilight® was kindly donated by 92 
Beghin Meiji. Gluzyme MONO10000 preparation was kindly donated by Novozymes. Yeast 93 
extract was purchased from Difco (Difco, MD, USA) and barley malt flour from Diagermal 94 
(IT).  95 
 96 
2.2. Flow chemistry equipment 97 
A R2+/R4 combination flow reactor commercially available from Vapourtec was used. 98 
The main R2+ system is driven by two integrated HPLC pumps; the flow rates can be 99 
regulated and set at any value between 0.01 to 10 mL/min working with a system pressure of 100 
up to 30 bar without any risk. The R4 heater guarantees a precise temperature control over the 101 
range room temperature to 150 °C in four independent controlled air-circulating heating 102 
zones, with a rapid temperature ramping and cooling (80 °C/min). The four reactor zones can 103 
each accept either a packed column or a flow tube arrangement providing reaction volumes of 104 
0.1 to 10 mL (or 40 mL in a linked sequential operation). A back-pressure regulator is applied 105 
in-line, if necessary. The system is also outfitted with a pair of injection loops that are 106 
positioned post the pumps. Finally, at the top, a large drip tray is located for reagents bottles 107 
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and collection vessels giving the whole system a very small compact foot print which fits 108 
comfortably into any fume cupboard. 109 
 110 
2.3. Strains and growth conditions 111 
C. cladosporioides, previously isolated and deposited at Mycotheca Universitatis 112 
Taurinenesis (MUT) as strain MUT 5506, was maintained as previously described (Zambelli, 113 
et al., 2014). 114 
Five probiotic Lactobacillus strains (Lactobacillus paracasei DG, Lactobacillus 115 
rhamnosus GG, Lactobacillus paracasei SHIROTA, Lactobacillus johnsonii LC1, 116 
Lactobacillus reuteri ATCC55730) used in this study were cultivated in MRS broth (Difco) 117 
and incubated at 37 °C for 24 hours. The bacterial cell concentration of an overnight culture 118 
was determined microscopically with a Neubauer improved counting chamber (Marienfeld 119 
GmbH, Lauda-Königshofen, Germany). For the assessment of in vitro blastose fermentation, 120 
strains were inoculated in triplicate at a final concentration of 4*105 bacteria/mL (from 121 
cultures grown overnight to the stationary phase). The medium used to test the growth with 122 
different sugars was API 50 CHL medium without glucose, prepared at different dilutions. 123 
The medium was added with a 0.5% concentration of different sugars (di- and 124 
oligosaccharides): glucose (as positive control), inulin, blastose, FOS-mixture, FOS-mixture 125 
without blastose and a commercially available mixture of FOS (Actilight®) (Taveriniti et al., 126 
2012). In vitro experiments were carried out in 384 well plates, filled by means of an 127 
automated pipetting system epMotion 5070 (Eppendorf, Germany). The microbial growth was 128 
monitored with a spectrophotometer (MicroWave RS2, Biotek, USA) programmed for 145-129 
290 readings (OD 600 nm) every 10 min for 24-48 h at 37 °C. At the end of the incubation, 130 
the µMax and the final OD at 600 nm were calculated using the software Gen5 (Biotek, USA) 131 
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and reported as the mean of three independent measurements ± standard deviation (Arioli et 132 
al., 2014). 133 
 134 
2.4. Fructofuranosidase activity assays  135 
The enzymatic activity towards sucrose was determined by measuring the initial rate of 136 
reducing sugar formation using the dinitrosalicylic acid (DNS) assay adapted to 96-well 137 
microplates (Rodrıguez, Perez, Ruiz, & Rodrıguez, 1995). Dried alginate entrapped (DALGE) 138 
mycelium (10 g/L) was incubated with 1 mL of a sucrose solution (100 g/L) in acetate buffer 139 
(20 mM pH 6.0) for 20 min at 50 ºC and 90 rpm. 50 μL of the solution, conveniently diluted 140 
to fit into the calibration curve, were added to each well. Then, 50 μL of 10 g/L DNS were 141 
added. The plate was incubated for 20 min at 80 ºC to develop colour with a seal plate tape 142 
(GeneMate). After cooling, 150 μL of water were added to each well, and the absorbance 143 
measured at 540 nm using a microplate reader (model Versamax, Molecular Devices). One 144 
unit (U) of activity was defined as that catalysing the formation of 1 μmol reducing sugar per 145 
minute under the above described conditions.  146 
 147 
2.5. Dried alginate entrapped (DALGE) mycelium   148 
The gel beads were prepared by ionotropic gelation following a slightly modified protocol 149 
previously developed by us (Fernandez-Arrojo et al., 2013). A 4% (w/v) sodium alginate 150 
solution was prepared in distilled water and stirred until a homogeneous clear solution was 151 
formed. The solution was left to settle for 2 h in order to eliminate all the air bubbles. The 152 
alginate solution was then gently mixed in a ratio 1:1 (w/w) with 40 g/L of lyophilized 153 
mycelia in 20 mM sodium acetate buffer (pH = 6.0) after 5 cycles of sonication at 15 kHz for 154 
1 min (Soniprep 150, MSE). The resulting mycelia–alginate mixture was then used as 155 




2.6. Biotransformation with DALGE-mycelium in batch  158 
40 g/L of DALGE-mycelium was added to a 600 g/L sucrose solution in sodium acetate 159 
buffer 20 mM pH 6.0 in a final volume of 2 mL, incubated at 50 °C in an orbital shaker at 90 160 
rpm. The biotransformations were followed for 144 h and analyzed by HPLC. 161 
 162 
2.7. Analytical HILIC-HPLC  163 
The analytical data were collected with a HPLC system composed by a Hitachi LaChrom 164 
L-7100 pump available from Merck (DE) equipped with a Sedex 75 evaporative light 165 
scattering detector (ELSD) available from Alfatech (FR). The chromatographic separation of 166 
products was performed with a Luna NH2 100 Å column (250 × 4.6 mm, particle size 5 μm, 167 
Phenomenex, Aschaffenburg, Germany) equipped with the corresponding guard column (4 × 168 
3.0 mm), and kept at 30 °C with a Merck T-6300 column thermostat. The mobile phase was 169 
acetonitrile/water (80:20 v/v) at a flow rate of 1.0 mL/min. The temperature of detection was 170 
set to 52 °C. EZ Chrome Elite software by Agilent was used for data management. 171 
 172 
2.8. Semi-Preparative HILIC-HPLC 173 
The semi-preparative purifications were performed with a commercially HPLC system 174 
composed by a Hitachi LaChrom L-7100 pump available from Merck equipped with a Sedex 175 
75 evaporative light scattering detector (ELSD) available from Alfatech. The 176 
chromatographic separation of products was performed with a Luna NH2 100 Å column (250 177 
× 10 mm, particle size 5 μm, Phenomenex, Aschaffenburg, Germany) at room temperature. 178 
The following gradient of was used:  179 
- 0’-30’ acetonitrile/water (80:20 v/v) 180 
- 30’-35’ switch to acetonitrile/water (50:50 v/v) 181 
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- 35’-40’ acetonitrile/water (50:50 v/v) 182 
- 40’-45’ switch to acetonitrile/water (80:20 v/v) 183 
- 45’-60’ acetonitrile/water (80:20 v/v). 184 
The flow rate was set to 4.7 mL/min. The temperature of detection was set to 52 °C. EZ 185 
Chrome Elite software by Agilent was used for data management. 186 
 187 
2.9. Calculation of the T/H index 188 
The transfructosylation/hydrolysis ratio (T/H index) was calculated using the following 189 
equation (Eq. 1):  190 
T/H = ([glucose] − [fructose])/[fructose]. 191 
Eq. 1. Transfructosylation/hydrolysis ratio (T/H) 192 
 193 
2.10. Productivity 194 
The productivities for batch and flow biotransformations were calculated at the same 195 
degree of conversion using the following equations (Eq. 2 and Eq. 3):  196 
rbatch
 = mp / (t × mE) 197 
Eq. 2. rbatch: batch productivity; mp: amount of the product of interest (mg); t: reaction 198 
time (min); mE: mass of the catalyst used (g). 199 
Rflow
 = [P] × f / mE 200 
Eq. 3. rflow: flow productivity; [P]: concentration of the product of interest (mg/mL); f: 201 
flow rate (mL/min); mE: mass of the catalyst packed in the reactor (g). 202 
 203 
2.11. Continuous flow biotransformation using alginate mycelia in a packed bed column 204 
Alginate beads and celite (1:1 w/w) were packed into an Omnifit® glass Column (15 mm 205 
id × 150 mm length). Each gram of alginate beads, mixed with the same volume of celite, can 206 
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fill about 6 mL of the inner volume of the column. The swelling of the dried beads was 207 
achieved with an acetate buffer solution (20 mM, pH 6) before connecting the column. A flow 208 
stream of 600 g/L sucrose solution in 20 mM sodium acetate buffer (pH 6) was pumped 209 
through the packed bed column, at different flow rates, in order to obtain residence times 210 
from 5 hours to 30 hours. The appropriate temperature was set by the R4 block heater. An 211 
aliquot (100 µL) of the exiting flow stream was diluted with water (1:3), the sample was 212 
filtered on a 0.45 µm nitrocellulose filter and analysed by HLIC-HPLC. 213 
 214 
2.12. Glucose oxidation with Gluzyme MONO 10000 BG  215 
The mixture obtained under optimized conditions after 20 hours of residence time has 216 
been exposed to the biocatalytic activity of a glucose oxidase preparation from Novozymes 217 
(Gluzyme MONO 10.000 BG) in batch (Sheu, Lio, Chen, Lin & Duan, 2001). To a 600 g/L 218 
mixture (20 mL) in acetate buffer 20 mM (pH 6) Gluzyme powder (800 mg, 400 U/mL) and 219 
CaCO3 (800 mg) were added. The resulted suspension was stirred at 35 °C insufflating air. 220 
The produced gluconic acid precipitated as calcium salt in the reaction flask. At different 221 
times, aliquots (100 µL) were withdrawn, diluted with water (1:3) and incubated for 10 min at 222 
90 ºC to inactivate the enzyme. Each sample was filtered on a 0.45 µm nitrocellulose filter 223 
and analysed. After 24 h the whole suspension was centrifuged at 14000 rpm for 30 min, 224 
filtered on a cellulose filter paper and used for preparative HPLC purification. 225 
 226 
3. Results and discussion 227 
In our previous work, we reported a method for the batch production of a new mixture of 228 
FOS, starting from a 600 g/L solution of sucrose using lyophilized mycelium of C. 229 
cladosporioides MUT 5506 in 20 mM acetate buffer (Zambelli, et al., 2014). The FOS 230 
mixture was characterized by the presence of a high variety of FOS, i.e., kestose (1-, 6- and 231 
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neo-), nystose (1-, 6-, and neo-), 1-fructofuranosylnystose and, interestingly, an unusual 232 
disaccharide named blastose. Given our great interest in investigating the potential prebiotic 233 
properties of this new type of FOS mixture, we decided to exploit the flow chemistry facilities 234 
to implement its production, with the aim of setting up a suitable process for the sustainable 235 
and scalable production of the desired FOS mixture on a large scale. Thus, we decided to 236 
perform the biotransformation into a meso-flow reactor, using immobilized mycelia of C. 237 
cladosporioides. Dried alginate entrapped (DALGE)-mycelium was identified as the suitable 238 
kind of immobilization for the application in a continuous flow reactor, due to the good 239 
stability over the time and during subsequent cycles of biotransformations. Moreover, 240 
alginates are economic and easy to prepare (Fernandez-Arrojo, et al., 2013).  241 
First, the reaction was performed in batch, following the procedure reported above. The 242 
higher conversion (total FOS amount ~ 51% w/w) was achieved after a prolonged reaction 243 
time (96 hours) and blastose appeared only after 48 hours with a maximum (4.9% w/w) at 168 244 
hours. We then moved to flow. To this aim, a glass column (10 mm id × 100 mm length) was 245 
packed with the DALGE-mycelium beads and a 600 g/L sucrose solution in 20 mM acetate 246 
buffer (pH 6.0) was flowed through it (Scheme 1). To avoid any unwanted and uncontrolled 247 
increase of the pressure due to a clogging, celite was mixed to the alginates before the 248 
packaging (alginate beads: celite = 1:1 v/v). In this way, no over-pressure was observed over 249 
the reaction time.  250 
Scheme 1 to be inserted here. 251 
We initially optimized the reaction parameters using the transfructosylation/hydrolysis 252 
ratio (T/H index) as an index of the transglycosylation rate. First, the temperature effect on 253 
the T/H index was evaluated (Figure 1). The residence time was kept constant at 5 h and the 254 
temperature was varied between 25 °C and 70 °C. The highest T/H index was obtained at 35 255 
°C, with a value of 4.0 ± 0.2. Then, the effect of the pressure on the biotransformation was 256 
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evaluated, keeping the temperature constant at 35 °C. Pressurization of the system was easily 257 
achieved applying in-line different backpressure regulators (40, 75, 100 and 250 psi). No 258 
significant differences in the T/H index were observed (Figure 1) and, for this reason, we 259 
decided not to use any back pressure regulator to avoid any negative influence of the 260 
prolonged pressurization on the stability of the enzyme and/or alginates over the time.  261 
Figure 1 to be inserted here. 262 
After having set the optimal operating conditions (i.e. T = 35 °C, atmospheric pressure), 263 
we analyzed the kinetic profile of the packed bed continuous-flow biotransformation and 264 
compared it to that obtained in batch with C. cladosporioides alginates in buffer. Considering 265 
the biotransformation catalyzed by DALGE-mycelium in acetate buffer (pH 6), the main 266 
products were 1-kestose, 1-nystose, 1-fructofuranosylnystose and blastose, with a maximum 267 
concentration of 139 g/L (23% w/w), 96 g/L (16% w/w), 15 g/L (2.5% w/w), and 30 g/L (5% 268 
w/w), respectively. Neo-kestose, neo-nystose and 6-kestose were found in a later stage of the 269 
biotransformation (after 48 h of reaction time), with a concentration below 12 g/L (< 2% 270 
w/w).  271 
In flow, working at atmospheric pressure and at a temperature of 35 °C, we considered 272 
the residence time and we evaluated the conversion in terms of total amount of FOS formed 273 
(Figure 2). The maximum amount of FOS was reached at 20 h of residence time and remained 274 
constant up to 30 h. At 20 h of residence time, the concentration of FOS was 313 g/L (52.2 % 275 
w/w), as represented in figure 2, with a concentration of 1-kestose, 1-nystose, 1-276 
fructofuranosylnystose and blastose of 139 g/L (23.2 % w/w), 86 g/L (14.3 % w/w), 39 g/L 277 
(6.5% w/w) and 28 g/L (4.7% w/w) respectively, and a concentration of neo-kestose, 6-278 
kestose and neo-nystose of 9 g/L (1.5% w/w), 6 g/L (1% w/w) and 6 g/L (1% w/w), 279 
respectively. It is worth noting that, after only 10 h of residence time, a 47.4 % (w/w) of 280 
conversion was already reached and that the total amount of FOS only slightly increased in 281 
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the following 10 hours. A similar conversion (48% w/w) was obtained in batch after 72 hours 282 
of reaction. A significant reduction of the reaction time is a typical benefit achieved on 283 
passing from batch to flow conditions, both for heterogeneous chemo- or bio-catalyzed 284 
reactions (Kirschning, Solodenko & Mennecke 2006; Puglisi, Benaglia & Chiroli, 2013). 285 
Focusing on blastose formation, as shown in Figure 2, blastose could be identified in the 286 
reaction flow stream after only 5 hours (residence time), and it reached a concentration of 28 287 
g/L (4.7% w/w) after 20 hours, whereas a similar concentration (30 g/L) could be obtained in 288 
batch only after 168 hours. Moreover, running the reaction in flow for additional ten hours 289 
(30 hours of total residence time), the amount of blastose increased up to 31 g/L (5.2% w/w) 290 
of the total solution.  291 
Figure 2 to be inserted here. 292 
To compare the batch and flow efficiencies for the FOS production, we determined the 293 
productivity values for both total FOS and blastose, at different reaction times, in these two 294 
different environments. In batch conditions (72 hours, total FOS ~ 48.0% w/w), we obtained a 295 
complex mixture of different FOS, with different degree of polymerization and structures, and 296 
a productivity of 1.66 mg/g*min. In flow, a similar FOS concentration (47.4%) was reached 297 
with a residence time of 10 hours. In these conditions, the productivity value was equal to 298 
2.84 mg/g*min, about 1.7 times the productivity obtained in batch. Considering blastose, the 299 
maximum value (30 g/L) in batch was reached after 168 hours. This corresponds to a 300 
productivity 0.07 mg/g*min. In flow, a similar concentration of blastose was obtained after 20 301 
hours of residence time: the productivity is 0.14 mg/g*min, two times the productivity 302 
obtained in batch.  303 
After the optimization of reaction parameters, we exploited the packed bed flow system 304 
for the continuous production of the new mixture of FOS. First, we evaluated the stability of 305 
the packed bed alginate beads over the time; to this aim, the conversion at 5 h of residence 306 
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time was evaluated during 7 days of continuous work. The reaction outcome was checked the 307 
first time, after 5 hours of residence time and, then, every 24 hours, for one week. A similar 308 
concentration of residual sucrose was observed in the monitored reaction time (Figure 3). The 309 
same packed column was then washed with the acetate buffer 20 mM and conserved at 4 °C 310 
for two months. The column was used again under the same reaction conditions and a similar 311 
conversion was obtained. This outcome highlights the possibility of using this set up for a 312 
continuous production over the time, without the need of replacing or recycling the 313 
biocatalyst. 314 
Figure 3 to be inserted here. 315 
Subsequently, we selected a residence time of 20 h, because the highest amount of total 316 
FOS is formed, including a 4.6% (w/w) of blastose, and we followed the production over 7 317 
days of continuous work, as represented in figure 4. It is important to note that, using the flow 318 
system, once fixed the residence time, a constant mixture of FOS can be produced. Indeed, 319 
the total FOS amount remains in a range of 51.7-53.0% (w/w) during the monitored reaction 320 
time.  321 
Figure 4 to be inserted here. 322 
Finally, we set up a suitable method for the purification of the FOS mixture from the 323 
reaction medium and for the isolation of the non-conventional sugar blastose, in order to 324 
submit them to biological investigation. Glucose is the main undesirable by-product in the 325 
synthesis of FOS catalyzed by trans-fructofuranosydases (Duan, Chen & Sheu, 1994). In the 326 
exiting flow stream, glucose represents the 26% (w/w) of the mixture and its presence 327 
complicates the purification of the FOS mixture, and, in particular, the isolation of blastose. 328 
Therefore, we exploited a method reported in the literature for glucose removal based on its 329 
enzymatic oxidation to gluconic acid catalyzed by a commercially available glucose oxidase 330 
(Gluzyme® mono 10000 BG, from Novozymes); the formed gluconate can be precipitated as 331 
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calcium salt and easily removed (Sheu, Lio, Chen, Lin & Duan, 2001; Biyela, Du Toit, Divol, 332 
Malherhe & Van Renshurg, 2009). A final semi-preparative HPLC step was necessary to 333 
obtain either the pure FOS mixture or the blastose (97% purity). 334 
In the last decade the concept of “prebiotic”, substrate that selectively stimulates the 335 
growth and activity of health-promoting Lactobacilli and Bifidobacteria, has assumed much 336 
interest in terms of improving human host health (Gimeno-Pérez, Linde, Fernández-Arrojo, 337 
Plou & Fernández-Lobato, 2014). In order to investigate the ability of probiotic strains to use 338 
blastose as the sole carbon source and thus its suitability for a potential application in 339 
symbiotic-prebiotic mixtures, an in vitro fermentation study was carried out on 5 well 340 
characterized probiotic Lactobacillus strains, easier to cultivate than Bifidobacteria: L. 341 
paracasei DG (Ferrario et al, 2014), L. rhamnosus GG (Segers and Leeber, 2014); L. 342 
paracasei SHIROTA (Aoki et al., 2014); L. johnsonii LC1 (Isobe et al., 2012); L. reuteri 343 
ATCC55730 (Di Nardo et al, 2014; Valeur, Engel, Carbajal, Connolly, & Ladefoged, 2004). 344 
In detail, Lactobacillus strains were grown in presence of glucose (considered as positive 345 
control) and two well known prebiotic substrates, i.e. inulin and FOS Actilight®. Then, the 346 
growth kinetic parameter (µmax value) and the final OD after 48 h of incubation were 347 
compared to that obtained in presence of our new FOS-mixture, our FOS-mixture without 348 
blastose and only blastose. The results are summarized in Table 1.  349 
Table 1 to be inserted here. 350 
All the Lactobacillus probiotics were able to growth in the presence of blastose as carbon 351 
source, except for L. reuteri strain, able to growth only in presence of glucose. Among the 352 
probiotics tested, L. paracasei DG and L. johnsonii LC1 showed the most efficient growths in 353 
presence of the non-conventional disaccharide, with an increase of the final OD of 50% and 354 
109% and higher µmaxs (>62% and >77%) in respect to glucose. These data indicate a growth 355 
stimulation effect of blastose. No increases of biomass production or µmax values were 356 
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observed for L. rhamnosus GG and L. casei Shirota, probably due to a less efficient 357 
disaccharide transport system in these species. More in general, the microorganisms, in the 358 
presence of blastose as sole carbon source, are able to reach higher OD and µmax than in the 359 
presence of other prebiotic substrates such as inulin and the FOS mixture Actilight®. 360 
Surprisingly, our new FOS mixture seems to be better metabolized than FOS Actilight® by L. 361 
rhamnosus and L. casei cells, reaching a major final OD value and an increased µmax. This 362 
effect is probably due to a different 1F-FOS amount compared to Actilight®, as well as the 363 
presence of about 5% of blastose (Zambelli et al., 2014). These positive results provide a first 364 
preliminary evidence on the potential in vitro prebiotic effect of the newly isolated blastose 365 
and of our new FOS mixture. Nevertheless, further in vitro and in vivo studies are needed in 366 
order to assess the effect of the new compound on other probiotic microorganisms and its 367 
possible use in prebiotic formulations. 368 
 369 
4. Conclusions 370 
A continuous production of a new mixture of fructooligosaccharides was performed 371 
exploiting the innovative combination of immobilized whole cells with a continuous flow 372 
chemistry reactor, leading to a significant improvement of the total FOS productivity (1.7 373 
times) and blastose productivity (2 times), compared to classical batch methods. Moreover, 374 
we ascertained the stability of our production system over the time and, indeed, we performed 375 
a 7 days continuous production cycle, being able to produce a mixture of FOS characterized 376 
by a constant composition. Hence, the use of a continuous flow reactor allowed to overcome 377 
some of the typical limitations of batch biotranformations, such as long reaction times, 378 
product inhibition, and scalability. 379 
These results suggest the suitability of the proposed method for a sustainable and scalable 380 
production of the desired FOS mixture, whose potential use as a novel prebiotic preparation 381 
17 
 
can be easily foreseen and is at present under investigation by us. The results presented here, 382 
even if only preliminary, indicate that blastose has prebiotic properties similar or higher than 383 
the reference prebiotics, i.e., inulin and a commercialized FOS mixture (Actilight®), 384 
depending on the probiotic species analyzed. This result represents the first indication that 385 
blastose has a positive influence on the growth of probiotic microorganisms and this can 386 
justify further in vivo assays conducted on animal models or human volunteers to ensure and 387 
better assess its prebiotic properties.  388 
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Figure and scheme captions 511 
 512 
Scheme 1. Schematic representation of the continuous system configuration used for 513 
pressure and temperature optimization. BPR: back pressure regulator. 514 
 515 
Figure 1. Graph of the T/H index in function of temperature (A) and pressure (B). A) 516 
Conditions: [sucrose]: 600 g/L in acetate buffer 20 mM (pH 6); alginate beads: 1 g; celite: 1 517 
g; residence time: 5 h; atmospheric pressure. B) Conditions: [sucrose]: 600 g/L in acetate 518 
buffer 20 mM (pH 6); alginate beads: 1 g; celite: 1 g; residence time: 5 h; T = 35 °C. Results 519 
are the average of three trials with standard deviations were lower than 5%. 520 
 521 
Figure 2. Total (A) and single (B) FOS amount at different residence times using a 522 
packed bed continuous flow reactor. Conditions: [sucrose]: 600 g/L in acetate buffer 20 mM 523 
(pH 6); alginate beads: 2 g; celite: 2 g; T = 35 °C; atmospheric pressure. Results are the 524 
average of three trials with standard deviations were lower than 5%. 525 
 526 
Figure 3. Sucrose residual concentration during 7 days of continuous work. Conditions: 527 
[sucrose]: 600 g/L in acetate buffer 20 mM (pH 6); alginate beads: 2 g; celite: 2 g; T = 35 °C; 528 
atmospheric pressure. Results are the average of three trials with standard deviations were 529 
lower than 5%. 530 
 531 
Figure 4. Continuous production of FOS under optimized conditions. Conditions: 532 
[sucrose]: 600 g/L in acetate buffer 20 mM (pH 6); alginate beads: 2 g; celite: 2 g; T = 35 °C; 533 
atmospheric pressure. Results are the average of three trials with standard deviations were 534 




Table 1. Growth parameters (OD 600 nm and µmax) of probiotics during the in vitro 537 
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Table 1. Growth parameters (OD600nm and µmax) of probiotics during the in vitro prebiotic 566 
assay. 567 
Carbohydrate 




L. casei  
SHIROTA 
L. johnsonii  
LC1 

















Glucose 1.20.07 0.290.07 1.90.03 0.710.002 1.60.08 0.430.09 1.10.01 0.490.05 1.50.01 0.10.01 
Inulin 0.90.03 0.260.03 0.90.01 0.320.03 1.10.03 0.280.00 0.80.01 0.210.02 n.d n.d 
FOS 
Actilight® 
1.50.02 0.340.03 0.740.05 0.130.03 n.d. n.d. 1.80.05 0.860.02 n.d n.d 
FOS mixture 1.4±0.05 0.390.03 1.20.07 0.400.03 1.60.03 0.360.01 1.90.05 0.820.02 n.d n.d 
FOS mixture 
(-blastose) 
1.40.04 0.380.09 1.10.07 0.350.02 1.10.04 0.350.03 2.00.01 0.210.02 n.d n.d 
Blastose 1.8±0.05 0.470.06 1.80.07 0.570.02 1.60.04 0.530.02 2.30.05 0.870.02 n.d n.d 
n.d: not detected growth after 48h of incubation at 37 °C 568 
 569 
